Koers Saber Capital Corp Toronto S.E.
Aandelen
SABh
CA78515A1012
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- | - |
|
Omzet 2017 | 2,69 0 2,51 | Omzet 2018 | 8,22 0 7,66 | Marktkapitalisatie | 119 mln. 0 111 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -12 mln. - -11,18 mln. | Nettowinst (verlies) 2018 | -24 mln. - -22,36 mln. | EV/omzet 2017 | 72.352.077 x |
Nettoliquiditeiten 2017 | 21,51 mln. 0 20,04 mln. | Nettoliquiditeiten 2018 | 29,05 mln. 0 27,07 mln. | EV/omzet 2018 | 10.915.686 x |
K/w-verhouding 2017 |
-16,3
x | K/w-verhouding 2018 |
-4,48
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 98,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tricia Symmes
CEO | Chief Executive Officer | - | - |
Nick Dean
PSD | President | - | 01-12-17 |
John H. Stewart
BRD | Director/Board Member | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Brian Morrison
BRD | Director/Board Member | 42 | - |
Director/Board Member | - | 06-11-18 | |
John H. Stewart
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,37% | 5,8 mld. | |
-27,13% | 3,92 mld. | |
+4,75% | 3,28 mld. | |
-20,80% | 2,77 mld. | |
-10,70% | 2,26 mld. | |
+49,04% | 1,95 mld. | |
-16,86% | 1,52 mld. | |
+49,16% | 1,49 mld. | |
-9,87% | 1,49 mld. |